You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cataplexy

Showing 1 - 25 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Narcolepsy, Narcolepsy Type 1, Narcolepsy With Cataplexy Trial in Chicago (Imagery rehearsal therapy, Targeted dream control)

Not yet recruiting
  • Narcolepsy
  • +4 more
  • Imagery rehearsal therapy
  • Targeted dream control
  • Chicago, Illinois
    Northwestern University
Jan 24, 2023

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Narcolepsy, Idiopathic Hypersomnia, Cataplexy Trial (Quantitative mass spectrometry assay)

Not yet recruiting
  • Narcolepsy
  • +2 more
  • Quantitative mass spectrometry assay
  • (no location specified)
Nov 7, 2022

Narcolepsy, Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy Trial in Chicago (Brief MBI, Standard MBI, Extended MBI)

Completed
  • Narcolepsy
  • +2 more
  • Brief MBI
  • +2 more
  • Chicago, Illinois
    Center for Circadian and Sleep Medicine, Northwestern University
Jun 30, 2022

Narcolepsy Without Cataplexy, Idiopathic Hypersomnia Trial in Atlanta (Clarithromycin, Placebo)

Recruiting
  • Narcolepsy Without Cataplexy
  • Idiopathic Hypersomnia
  • Atlanta, Georgia
    Emory Sleep Center
Jun 15, 2022

Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy Trial in Worldwide (pitolisant, Placebo)

Active, not recruiting
  • Narcolepsy With Cataplexy
  • Narcolepsy Without Cataplexy
  • Helsinki, Finland
  • +10 more
Dec 28, 2021

Hypersomnia Trial in Columbus (Transcranial Direct Current Stimulation, Sham stimulation)

Terminated
Has Results
  • Hypersomnia
  • Transcranial Direct Current Stimulation
  • Sham stimulation
  • Columbus, Ohio
    The Ohio State University
Oct 22, 2021

Idiopathic Hypersomnia, Narcolepsy Without Cataplexy Trial in Atlanta (Modafinil, Amphetamine-Dextroamphetamine)

Recruiting
  • Idiopathic Hypersomnia
  • Narcolepsy Without Cataplexy
  • Atlanta, Georgia
    Emory Sleep Center
Jul 13, 2022

Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

Enrolling by invitation
  • Narcolepsy
  • +2 more
  • AXS-12 (reboxetine)
  • Placebo
  • Santa Ana, California
  • +18 more
Sep 23, 2022

Narcolepsy With Cataplexy, Narcolepsy, Narcolepsy Without Cataplexy Trial in United States (Mazindol)

Enrolling by invitation
  • Narcolepsy With Cataplexy
  • +2 more
  • Birmingham, Alabama
  • +21 more
Jun 1, 2022

Narcolepsy Type 1 Trial in United States (TAK-861, Placebo)

Recruiting
  • Narcolepsy Type 1
  • Birmingham, Alabama
  • +6 more
Jan 31, 2023

Narcolepsy Trial in United States (SEP363856, Placebo)

Completed
  • Narcolepsy
  • Orange, California
  • +5 more
Aug 16, 2021

Narcolepsy Trial in Canada, United States (SUVN-G3031, Placebo)

Recruiting
  • Narcolepsy
  • Birmingham, Alabama
  • +40 more
Sep 9, 2022

Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

Recruiting
  • Narcolepsy
  • +2 more
  • AXS-12 (reboxetine)
  • Placebo
  • Alabaster, Alabama
  • +45 more
Sep 23, 2022

Narcolepsy With Cataplexy, Healthy Controls Trial in Toronto (Xyrem)

Completed
Has Results
  • Narcolepsy With Cataplexy
  • Healthy Controls
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health (CAMH)
Feb 26, 2021

Narcolepsy Type 2 Trial in United States (TAK-861, Placebo)

Recruiting
  • Narcolepsy Type 2
  • Birmingham, Alabama
  • +6 more
Jan 31, 2023

Excessive Daytime Sleepiness, Cataplexy, Narcolepsy Trial in Worldwide (FT218, Placebo)

Completed
Has Results
  • Excessive Daytime Sleepiness
  • +2 more
  • Anniston, Alabama
  • +56 more
Mar 18, 2022

Narcolepsy, Excessive Daytime Sleepiness, Cataplexy Narcolepsy Trial in United States (mazindol extended release, Placebo)

Completed
  • Narcolepsy
  • +2 more
  • mazindol extended release
  • Placebo
  • Birmingham, Alabama
  • +21 more
Aug 11, 2022

Narcolepsy, Cataplexy Narcolepsy, Excessive Sleepiness Trial in United States (AXS-12 (Reboxetine), Placebo)

Completed
  • Narcolepsy
  • +2 more
  • AXS-12 (Reboxetine)
  • Placebo
  • Birmingham, Alabama
  • +13 more
Dec 8, 2020

Narcolepsy Type 1 Trial in Russian Federation (no intervention)

Active, not recruiting
  • Narcolepsy Type 1
  • no intervention
  • Chelyabinsk, Russian Federation
  • +10 more
Aug 10, 2022

Narcolepsy With Cataplexy Trial in Worldwide (JZP-258, Placebo)

Completed
Has Results
  • Narcolepsy With Cataplexy
  • Orange, California
  • +24 more
Nov 10, 2020

'A Profile of Physical Performance Variables inOut-patient Adult

Suspended
  • Narcolepsy
  • +6 more
  • Assessment of physical performance variables
  • Dublin, Ireland
    Department of Physiotherapy, School of Medicine, Trinity College
Jun 4, 2020

Physical Activity Program on the Severity of Narcolepsy

Not yet recruiting
  • Narcolepsy Type 1
  • Physical activity training program
  • +2 more
  • Lyon, France
    Service de médecine du sommeil et des maladies respiratoires
Jul 12, 2022

Narcolepsy Trial in Taoyuan ("MAGSTIM" reprtitive Transcranial Magnetic Stimulator (rTMS) System, sham control)

Recruiting
  • Narcolepsy
  • "MAGSTIM" reprtitive Transcranial Magnetic Stimulator (rTMS) System
  • sham control
  • Taoyuan, Taiwan
    Chang-Gung Memorial Hospital
May 30, 2023

Narcolepsy Type 1, Narcolepsy Type 2 Trial (TAK-861)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy Type 2
  • (no location specified)
Mar 31, 2023